Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05257317
Other study ID # 2019/302
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date February 2022
Est. completion date September 2023

Study information

Verified date February 2022
Source Escoles Universitaries Gimbernat
Contact Maider Sánchez-Padilla, MSc
Phone 0034 93 589 37 27
Email maider.sanchez@eug.es
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Insomnia is the most prevalent sleep disorder in society. The first treatment of choice is pharmacology, although it can have secondary effects such as tolerance and dependence, or alter the structure of sleep; therefore, new pathways towards other adjuvant treatments are being established. OBJECTIVES: The main objective is "To assess the effectiveness of manual cranial therapy on the quantity and quality of sleep in patients with chronic insomnia." MATERIAL AND METHODS: A randomized clinical trial is designed, with two groups, intervention and placebo, to assess the effectiveness of manual therapy applied to the skull, in the severity of insomnia, and quantity and quality of sleep in patients with sleep disorder. chronic insomnia. Health professionals will be selected from the Department of Occupational Health, with characteristics of chronic insomnia described by the ICSD-III, who do not modify their usual medication regimen (if they take it) and without other pathologies related to sleep that may be causing the insomnia. insomnia Demographic data (age, sex, profession), clinical (BMI, history of previous and family insomnia pathologies, and taking medication for sleep and related disorders), sleep quality questionnaires (PSQI, COS, ISI) will be collected. , stress-insomnia relationship (FISRST-S), and quality of life (SF12), in addition to filling out a sleep diary (through the mobile App) and recording activity through actigraphy, hypnogram (Sleep ProfilerTM); before and after the intervention, and at one and three month follow-up. Each group will receive the offered intervention: cranial manual therapy (intervention) or cranial massage (placebo). The data will be coded and analyzed with the IBM SPSS® version 20 program (or similar)


Recruitment information / eligibility

Status Recruiting
Enrollment 50
Est. completion date September 2023
Est. primary completion date December 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - Diagnosed with chronic insomnia disorder according to the criteria defined by the ICSD-III (International Classification of Sleep Disorders-3rd edition): - Problems initiating or maintaining sleep, associated with daytime consequences; and not attributable to environmental circumstances. - Insomnia lasting more than 3 months, with episodes of at least 3 times a week. - Regarding the pharmacology or medication indicated for sleep: - They do not want to take the medication recommended by the doctor who is treating them. - Do not change their usual drug regimen, if they were already taking medication to sleep. - They are not taxed to take medication. - Having ruled out other pathologies related to sleep through: - Respiratory polygraphy to rule out sleep-related respiratory pathologies (SAHS). - screening to rule out motor sleep disorders. - screening to rule out circadian sleep disorders. - screening to rule out serious psychiatric disorders (depression, anxiety, general psychopathology): BDI-II (Beck Depression Inventory), BAI (Beck Anxiety Inventory), SCL-90. - Obtain a score greater than 7 points (clinical-subclinical insomnia). Exclusion Criteria: - Obtain a score of less than 7 (clinically insignificant insomnia) in the ISI test (Insomnia Severity Index). - The result of the respiratory polygraphy is positive, confirming a sleep-disordered breathing. - The screening tests for the detection of motor sleep disorders, respiratory sleep disorders or circadian disorders are positive. - The Screening detects serious psychiatric illnesses such as major depressive disorder or bipolar disorders is positive. - Suffering or having suffered from any central neurological pathology, stroke, aneurysm... - Having suffered skull fractures. - Having undergone surgery in the last 6 months and that insomnia has started as a result of it.

Study Design


Related Conditions & MeSH terms

  • Disease
  • Sleep Initiation and Maintenance Disorders

Intervention

Other:
Osteopathic Medicine
Where compression and traction movements will be carried out on these structures. Technique called CV4, applied on the occipital, and Technique called asynchronous rolling of the temporal bones.
Placebo therapy
Circular movements will be induced in a frontal and parietal bones

Locations

Country Name City State
Spain Escoles Universitaries Gimbernat Sant Cugat Del Vallès Barcelona

Sponsors (2)

Lead Sponsor Collaborator
Escoles Universitaries Gimbernat Corporacion Parc Tauli

Country where clinical trial is conducted

Spain, 

References & Publications (48)

Bastien CH, St-Jean G, Morin CM, Turcotte I, Carrier J. Chronic psychophysiological insomnia: hyperarousal and/or inhibition deficits? An ERPs investigation. Sleep. 2008 Jun;31(6):887-98. — View Citation

Bastien CH, Vallières A, Morin CM. Validation of the Insomnia Severity Index as an outcome measure for insomnia research. Sleep Med. 2001 Jul;2(4):297-307. — View Citation

Benca RM. Diagnosis and treatment of chronic insomnia: a review. Psychiatr Serv. 2005 Mar;56(3):332-43. Review. — View Citation

Bialosky JE, Bishop MD, Price DD, Robinson ME, George SZ. The mechanisms of manual therapy in the treatment of musculoskeletal pain: a comprehensive model. Man Ther. 2009 Oct;14(5):531-8. doi: 10.1016/j.math.2008.09.001. Epub 2008 Nov 21. — View Citation

Curtis BJ, Williams PG, Jones CR, Anderson JS. Sleep duration and resting fMRI functional connectivity: examination of short sleepers with and without perceived daytime dysfunction. Brain Behav. 2016 Sep 15;6(12):e00576. doi: 10.1002/brb3.576. eCollection — View Citation

Cutler MJ, Holland BS, Stupski BA, Gamber RG, Smith ML. Cranial manipulation can alter sleep latency and sympathetic nerve activity in humans: a pilot study. J Altern Complement Med. 2005 Feb;11(1):103-8. — View Citation

D'Alonzo GE, Krachman SL. Circadian rhythm sleep disorders. J Am Osteopath Assoc. 2000 Aug;100(8 Suppl):S15-21. Review. — View Citation

Dodds KL, Miller CB, Kyle SD, Marshall NS, Gordon CJ. Heart rate variability in insomnia patients: A critical review of the literature. Sleep Med Rev. 2017 Jun;33:88-100. doi: 10.1016/j.smrv.2016.06.004. Epub 2016 Jun 28. Review. — View Citation

Durmer JS, Dinges DF. Neurocognitive consequences of sleep deprivation. Semin Neurol. 2005 Mar;25(1):117-29. Review. — View Citation

Equihua-Benítez AC, Guzmán-Vásquez K, Drucker-Colín R. Understanding sleep-wake mechanisms and drug discovery. Expert Opin Drug Discov. 2017 Jul;12(7):643-657. doi: 10.1080/17460441.2017.1329818. Epub 2017 May 22. Review. — View Citation

Grønli J, Soulé J, Bramham CR. Sleep and protein synthesis-dependent synaptic plasticity: impacts of sleep loss and stress. Front Behav Neurosci. 2014 Jan 21;7:224. doi: 10.3389/fnbeh.2013.00224. eCollection 2013. Review. — View Citation

Halász P, Bódizs R, Parrino L, Terzano M. Two features of sleep slow waves: homeostatic and reactive aspects--from long term to instant sleep homeostasis. Sleep Med. 2014 Oct;15(10):1184-95. doi: 10.1016/j.sleep.2014.06.006. Epub 2014 Jul 8. Review. — View Citation

Hurley DA, Eadie J, O'Donoghue G, Kelly C, Lonsdale C, Guerin S, Tully MA, van Mechelen W, McDonough SM, Boreham CA, Heneghan C, Daly L. Physiotherapy for sleep disturbance in chronic low back pain: a feasibility randomised controlled trial. BMC Musculosk — View Citation

Jackowska M, Dockray S, Endrighi R, Hendrickx H, Steptoe A. Sleep problems and heart rate variability over the working day. J Sleep Res. 2012 Aug;21(4):434-40. doi: 10.1111/j.1365-2869.2012.00996.x. Epub 2012 Feb 7. — View Citation

Jäkel A, von Hauenschild P. Therapeutic effects of cranial osteopathic manipulative medicine: a systematic review. J Am Osteopath Assoc. 2011 Dec;111(12):685-93. Review. — View Citation

Kingston J, Raggio C, Spencer K, Stalaker K, Tuchin PJ. A review of the literature on chiropractic and insomnia. J Chiropr Med. 2010 Sep;9(3):121-6. doi: 10.1016/j.jcm.2010.03.003. — View Citation

Levendowski DJ, Popovic D, Berka C, Westbrook PR. Retrospective cross-validation of automated sleep staging using electroocular recording in patients with and without sleep disordered breathing. Int Arch Med. 2012 Jun 25;5(1):21. doi: 10.1186/1755-7682-5- — View Citation

Lomeli HA, Pérez-Olmos I, Talero-Gutiérrez C, Moreno CB, González-Reyes R, Palacios L, de la Peña F, Muñoz-Delgado J. Sleep evaluation scales and questionaries: a review. Actas Esp Psiquiatr. 2008 Jan-Feb;36(1):50-9. Review. — View Citation

Lozano López C, Mesa Jiménez J, de la Hoz Aizpurúa JL, Pareja Grande J, Fernández de Las Peñas C. Efficacy of manual therapy in the treatment of tension-type headache. A systematic review from 2000-2013. Neurologia. 2016 Jul-Aug;31(6):357-69. doi: 10.1016/j.nrl.2014.01.002. Epub 2014 May 22. Review. English, Spanish. — View Citation

McCall WV. Cognitive behavioral therapy for insomnia (CBT-I): What is known, and advancing the science by avoiding the pitfalls of the placebo effect. Sleep Med Rev. 2018 Apr;38:1-2. doi: 10.1016/j.smrv.2017.05.001. Epub 2017 May 5. — View Citation

Medrano-Martínez P, Ramos-Platón MJ. [Cognitive and emotional alterations in chronic insomnia]. Rev Neurol. 2016 Feb 16;62(4):170-8. Review. Spanish. — View Citation

Meerlo P, Koehl M, van der Borght K, Turek FW. Sleep restriction alters the hypothalamic-pituitary-adrenal response to stress. J Neuroendocrinol. 2002 May;14(5):397-402. — View Citation

Merino-Andreu M, Alvarez-Ruiz de Larrinaga A, Madrid-Perez JA, Martinez-Martinez MA, Puertas-Cuesta FJ, Asencio-Guerra AJ, Romero Santo-Tomas O, Jurado-Luque MJ, Segarra-Isern FJ, Canet-Sanz T, Gimenez-Rodriguez P, Teran-Santos J, Alonso-Alvarez ML, Garcia-Borreguero Diaz-Varela D, Barriuso-Esteban B. [Healthy sleep: evidence and guidelines for action. Official document of the Spanish Sleep Society]. Rev Neurol. 2016 Oct 3;63(s02):1. Spanish. — View Citation

Miana L, Bastos VH, Machado S, Arias-Carrión O, Nardi AE, Almeida L, Ribeiro P, Machado D, King H, Silva JG. Changes in alpha band activity associated with application of the compression of fourth ventricular (CV-4) osteopathic procedure: a qEEG pilot stu — View Citation

Molen YF, Carvalho LB, Prado LB, Prado GF. Insomnia: psychological and neurobiological aspects and non-pharmacological treatments. Arq Neuropsiquiatr. 2014 Jan;72(1):63-71. doi: 10.1590/0004-282X20130184. Review. Erratum in: Arq Neuropsiquiatr. 2014 Feb;72(2):174. — View Citation

Morgenthaler T, Alessi C, Friedman L, Owens J, Kapur V, Boehlecke B, Brown T, Chesson A Jr, Coleman J, Lee-Chiong T, Pancer J, Swick TJ; Standards of Practice Committee; American Academy of Sleep Medicine. Practice parameters for the use of actigraphy in the assessment of sleep and sleep disorders: an update for 2007. Sleep. 2007 Apr;30(4):519-29. — View Citation

Morin CM, Belleville G, Bélanger L, Ivers H. The Insomnia Severity Index: psychometric indicators to detect insomnia cases and evaluate treatment response. Sleep. 2011 May 1;34(5):601-8. — View Citation

Morin CM, Benca R. Chronic insomnia. Lancet. 2012 Mar 24;379(9821):1129-41. doi: 10.1016/S0140-6736(11)60750-2. Epub 2012 Jan 20. Review. Erratum in: Lancet. 2012 Apr 21;379(9825):1488. — View Citation

Nijs J, Mairesse O, Neu D, Leysen L, Danneels L, Cagnie B, Meeus M, Moens M, Ickmans K, Goubert D. Sleep Disturbances in Chronic Pain: Neurobiology, Assessment, and Treatment in Physical Therapist Practice. Phys Ther. 2018 May 1;98(5):325-335. doi: 10.1093/ptj/pzy020. Review. — View Citation

Nofzinger EA, Buysse DJ, Germain A, Price JC, Miewald JM, Kupfer DJ. Functional neuroimaging evidence for hyperarousal in insomnia. Am J Psychiatry. 2004 Nov;161(11):2126-8. — View Citation

Ohayon MM, Sagales T. Prevalence of insomnia and sleep characteristics in the general population of Spain. Sleep Med. 2010 Dec;11(10):1010-8. doi: 10.1016/j.sleep.2010.02.018. Epub 2010 Nov 18. — View Citation

Ohayon MM. Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med Rev. 2002 Apr;6(2):97-111. — View Citation

Qaseem A, Kansagara D, Forciea MA, Cooke M, Denberg TD; Clinical Guidelines Committee of the American College of Physicians. Management of Chronic Insomnia Disorder in Adults: A Clinical Practice Guideline From the American College of Physicians. Ann Intern Med. 2016 Jul 19;165(2):125-33. doi: 10.7326/M15-2175. Epub 2016 May 3. — View Citation

Riemann D, Nissen C, Palagini L, Otte A, Perlis ML, Spiegelhalder K. The neurobiology, investigation, and treatment of chronic insomnia. Lancet Neurol. 2015 May;14(5):547-58. doi: 10.1016/S1474-4422(15)00021-6. Epub 2015 Apr 12. Review. — View Citation

Riemann D, Spiegelhalder K, Feige B, Voderholzer U, Berger M, Perlis M, Nissen C. The hyperarousal model of insomnia: a review of the concept and its evidence. Sleep Med Rev. 2010 Feb;14(1):19-31. doi: 10.1016/j.smrv.2009.04.002. Epub 2009 May 28. Review. — View Citation

Riemann D, Voderholzer U, Spiegelhalder K, Hornyak M, Buysse DJ, Nissen C, Hennig J, Perlis ML, van Elst LT, Feige B. Chronic insomnia and MRI-measured hippocampal volumes: a pilot study. Sleep. 2007 Aug;30(8):955-8. — View Citation

Riha RL. Diagnostic approaches to respiratory sleep disorders. J Thorac Dis. 2015 Aug;7(8):1373-84. doi: 10.3978/j.issn.2072-1439.2015.08.28. Review. — View Citation

Sateia MJ, Buysse DJ, Krystal AD, Neubauer DN, Heald JL. Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline. J Clin Sleep Med. 2017 Feb 15;13(2):307-349. doi: 10.5664/jcsm.6470. — View Citation

Sateia MJ. International classification of sleep disorders-third edition: highlights and modifications. Chest. 2014 Nov;146(5):1387-1394. doi: 10.1378/chest.14-0970. Review. — View Citation

Schmid A, Brunner F, Wright A, Bachmann LM. Paradigm shift in manual therapy? Evidence for a central nervous system component in the response to passive cervical joint mobilisation. Man Ther. 2008 Oct;13(5):387-96. doi: 10.1016/j.math.2007.12.007. Epub 2008 Mar 3. — View Citation

Schutte-Rodin S, Broch L, Buysse D, Dorsey C, Sateia M. Clinical guideline for the evaluation and management of chronic insomnia in adults. J Clin Sleep Med. 2008 Oct 15;4(5):487-504. — View Citation

Shergis JL, Ni X, Jackson ML, Zhang AL, Guo X, Li Y, Lu C, Xue CC. A systematic review of acupuncture for sleep quality in people with insomnia. Complement Ther Med. 2016 Jun;26:11-20. doi: 10.1016/j.ctim.2016.02.007. Epub 2016 Feb 18. Review. — View Citation

Shi X, Rehrer S, Prajapati P, Stoll ST, Gamber RG, Downey HF. Effect of cranial osteopathic manipulative medicine on cerebral tissue oxygenation. J Am Osteopath Assoc. 2011 Dec;111(12):660-6. — View Citation

Short NA, Allan NP, Raines AM, Schmidt NB. The effects of an anxiety sensitivity intervention on insomnia symptoms. Sleep Med. 2015 Jan;16(1):152-9. doi: 10.1016/j.sleep.2014.11.004. Epub 2014 Nov 25. — View Citation

Thorpy MJ. Classification of sleep disorders. Neurotherapeutics. 2012 Oct;9(4):687-701. doi: 10.1007/s13311-012-0145-6. Review. — View Citation

Toro-Velasco C, Arroyo-Morales M, Fernández-de-Las-Peñas C, Cleland JA, Barrero-Hernández FJ. Short-term effects of manual therapy on heart rate variability, mood state, and pressure pain sensitivity in patients with chronic tension-type headache: a pilot — View Citation

Veqar Z, Hussain ME. Validity and reliability of insomnia severity index and its correlation with pittsburgh sleep quality index in poor sleepers among Indian university students. Int J Adolesc Med Health. 2017 Jan 7;32(1). pii: /j/ijamh.2020.32.issue-1/ijamh-2016-0090/ijamh-2016-0090.xml. doi: 10.1515/ijamh-2016-0090. — View Citation

Xie Z, Chen F, Li WA, Geng X, Li C, Meng X, Feng Y, Liu W, Yu F. A review of sleep disorders and melatonin. Neurol Res. 2017 Jun;39(6):559-565. doi: 10.1080/01616412.2017.1315864. Epub 2017 May 1. Review. — View Citation

* Note: There are 48 references in allClick here to view all references

Outcome

Type Measure Description Time frame Safety issue
Primary Insomnia Severity With an "Insomnia Severity Index" (ISI). There are seven items. Each item is rated on a scale from 0 to 4 from less to more severe. The total score is the sum of each individual item and can range from 0 to 28 (28 = most severe insomnia). 18 weeks
Secondary Sleep Quality With a "Pittsburgh Sleep Quality Index (PSQI)" It consists of 19 items that analyze: quality, latency, duration, efficiency and sleep disturbances, use of sleeping medication and daytime dysfunction. The scores of the questions allows between 0 and 3 points for each of the seven subscales, where in all cases a score of "0" indicates ease, while a score of "3" indicates severe difficulty within its respective area. The sum of the seven subscales allows obtaining a global score between 0 and 21 for the entire scale, where "0" indicates ease of sleeping and "21" severe difficulty in all areas. 18 weeks
Secondary Sleep Quality With a "Cuestionario del SueƱo de Oviedo (COS)". It consists of 15 items, 13 of which are grouped into 3 scales:
Subjective sleep satisfaction (1 item): score from 1 to 7.
Insomnia (9 items) The scoring range is from 9 to 45, higher score indicate greater severity.
Hypersomnia (3 items): from 3 to 15 points, higher score indicate greater daytime disability.
18 weeks
Secondary Vulnerability to stress-related insomnia With FORD INSOMNIA RESPONSE TO STRESS spanish (FIRST-S). It is a scale that assesses vulnerability to stress-related insomnia. It is a standardized questionnaire with high test-retest reliability, which has been validated as a predictive measure of sleep vulnerability using polysomnographically measured sleep. It is made up of nine items and requires the individual to rate between 1 (not at all common) and 4 (very common) the probability of having sleep disturbance in association with specific and common stressful events or periods of stress that occur during the day or at night .
The total score of the answers obtained is quantified. High scores are indicative of increased vulnerability to stress-related insomnia. The cut-off score to detect individuals with this vulnerability is 19 points or higher, indicating "high-FIRST sleep reactivity."
9 weeks
Secondary Quality of Life of patients with insomnia With a 12-items Short-Form Health Survey (SF12). It consists of 12 items from the 8 dimensions of the SF-36 Physical Function (2), Social Function (1), Physical Role (2), Emotional Role (2), Mental Health (2), Vitality (1), Body Pain (1), General Health (1). The response options form Likert-type scales that assess intensity or frequency. The number of response options ranges from three to six, depending on the item.
For each of the 8 dimensions that it identifies, the items are coded, aggregated and transformed into a scale ranging from 0 (the worst state of health for that dimension) to 100 (the best state of health).
18 weeks
Secondary Quantity, latency and efficiency of sleep With a "Sleep Diary" 18 weeks
Secondary Quantity, latency and efficiency of sleep With an "Actigraphy record" 18 weeks
Secondary Hypnogram-Polysomnography - Macro and microstructure of sleep With a "WachPAt(R) device" 18 weeks
Secondary Heart Rate Variability With a "Polar H10 band" and "EliteHRV" app 4 weeks
See also
  Status Clinical Trial Phase
Enrolling by invitation NCT03276585 - Night in Japan Home Sleep Monitoring Study
Recruiting NCT05000528 - Evaluation of the Effectiveness of Patient Therapeutic Education on Chronic Insomnia N/A
Completed NCT04661306 - The Better Sleep for Supporters With Insomnia Study N/A
Completed NCT03673397 - The Acute Effect of Aerobic Exercise on Sleep in Patients With Depression N/A
Completed NCT01784614 - A Study of LY2624803 in Japanese Participants With Transient Insomnia Phase 1
Completed NCT00365261 - Effect of Eszopiclone on Sleep Disturbance and Pain in Cancer Phase 4
Completed NCT00380003 - Efficacy Study of EVT 201 to Treat Insomnia Phase 2
Completed NCT00183378 - Using Behavioral Programs to Treat Sleep Problems in Individuals With Alzheimer's Disease N/A
Completed NCT00946530 - Light Treatment for Sleep/Wake Disturbances in Alzheimer's Disease N/A
Completed NCT00097604 - Effects of Valerian on Sleep in Healthy Older Adults Phase 2
Completed NCT00630175 - Evaluation of the Hypnotic Properties of Zolpidem-MR 12.5 mg and Zolpidem 10 mg Marketed Product Compared to Placebo in Patients With Primary Insomnia Phase 3
Completed NCT00044629 - Combined Behavioral/Pharmacological Therapy for Insomnia Phase 2
Completed NCT00079664 - Comparing Tai Chi Training to a Low-Stress Physical Activity to Enhance Sleep in Older Adults Phase 1
Completed NCT01154023 - Behavioral Intervention for Insomnia in Older Adults N/A
Recruiting NCT04417153 - Who Benefits More? Optimising Mindfulness Based Interventions for Improved Psychological Outcomes
Completed NCT04560595 - Remote Guided Caffeine Reduction N/A
Recruiting NCT04986007 - Addressing Nocturnal Sleep/Wake Effects on Risk of Suicide in Older Adults N/A
Completed NCT03852966 - Better Sleep in Psychiatric Care - ADHD Pilot Study N/A
Terminated NCT00750919 - Twenty-six Week Extension Trial of Org 50081 (Esmirtazapine) in Outpatients With Chronic Primary Insomnia (176003/P05721/MK-8265-007) Phase 3
Recruiting NCT04550507 - Mind-Body Interventions to Mitigate Effects of Media Use on Sleep in Early Adolescents N/A